94 related articles for article (PubMed ID: 30328313)
1. Microdontia after chemotherapy in a patient treated for neuroblastoma: Histopathological findings.
Jodłowska A; Pająk J; Postek-Stefańska L
Dent Med Probl; 2018; 55(3):343-349. PubMed ID: 30328313
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of chemotherapy on dental status in children treated for nephroblastoma.
Marec-Berard P; Azzi D; Chaux-Bodard AG; Lagrange H; Gourmet R; Bergeron C
Pediatr Hematol Oncol; 2005; 22(7):581-8. PubMed ID: 16166051
[TBL] [Abstract][Full Text] [Related]
3. Microdontia after chemotherapy in a child treated for neuroblastoma.
Remmers D; Bökkerink JP; Katsaros C
Orthod Craniofac Res; 2006 Nov; 9(4):206-10. PubMed ID: 17101028
[TBL] [Abstract][Full Text] [Related]
4. Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
Minicucci EM; Lopes LF; Crocci AJ
Leuk Res; 2003 Jan; 27(1):45-50. PubMed ID: 12479851
[TBL] [Abstract][Full Text] [Related]
5. [Impact of radiation and antimitotic chemotherapy on the teeth. Apropos of 3 cases].
Salagnac JM
Rev Stomatol Chir Maxillofac; 1989; 90(5):320-4. PubMed ID: 2678415
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
7. [Late morphological teeth changes in children after chemotherapy].
Korolenkova MV
Stomatologiia (Mosk); 2015; 94(3):45-49. PubMed ID: 26271703
[TBL] [Abstract][Full Text] [Related]
8. Prosthodontic management of abnormal tooth development secondary to chemoradiotherapy: a clinical report.
Zwetchkenbaum SR; Oh WS
J Prosthet Dent; 2007 Dec; 98(6):429-35. PubMed ID: 18061736
[TBL] [Abstract][Full Text] [Related]
9. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma].
Feng C; Tang SQ; Wang JW; Liu Y; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):885-7. PubMed ID: 20113653
[TBL] [Abstract][Full Text] [Related]
10. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
[TBL] [Abstract][Full Text] [Related]
11. Hemophagocytic Lymphohistiocytosis After Initiation of Chemotherapy for Bilateral Adrenal Neuroblastoma.
Nascimento FA; Nery J; Trennepohl J; Pianovski MA
J Pediatr Hematol Oncol; 2016 Jan; 38(1):e13-5. PubMed ID: 26583611
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy as a therapeutic option for congenital neuroblastoma complicated by paraplegia.
Walter KN; Kratz C; Uhl M; Niemeyer C
Klin Padiatr; 2008; 220(3):175-7. PubMed ID: 18478490
[TBL] [Abstract][Full Text] [Related]
13. Abnormal odontogenesis in children treated with radiation and chemotherapy: imaging findings.
Kaste SC; Hopkins KP; Jenkins JJ
AJR Am J Roentgenol; 1994 Jun; 162(6):1407-11. PubMed ID: 8192008
[TBL] [Abstract][Full Text] [Related]
14. Oral manifestations of Ehlers-Danlos syndrome type VII: histological examination of a primary tooth.
Ooshima T; Abe K; Kohno H; Izumitani A; Sobue S
Pediatr Dent; 1990; 12(2):102-6. PubMed ID: 2133934
[TBL] [Abstract][Full Text] [Related]
15. Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H; Michon J; Plantaz D; Peyroulet MC; Coze C; Frappaz D; Chastagner P; Baranzelli MC; Méchinaud F; Boutard P; Lutz P; Perel Y; Leverger G; de Lumley L; Millot F; Stéphan JL; Margueritte G; Hartmann O
Br J Cancer; 1998 Jun; 77(12):2310-7. PubMed ID: 9649151
[TBL] [Abstract][Full Text] [Related]
16. Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation.
Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Wolf J; Nyström M; Hovi L
Bone Marrow Transplant; 2002 Jan; 29(2):121-7. PubMed ID: 11850706
[TBL] [Abstract][Full Text] [Related]
17. Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy.
Ishii E; Yoshida N; Miyazaki S
Eur J Pediatr; 1984 Dec; 143(2):152-3. PubMed ID: 6519114
[TBL] [Abstract][Full Text] [Related]
18. Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?
Bernard JL; Philip T; Zucker JM; Frappaz D; Robert A; Margueritte G; Boilletot A; Philippe N; Lutz P; Roche H
J Clin Oncol; 1987 Dec; 5(12):1952-9. PubMed ID: 3681378
[TBL] [Abstract][Full Text] [Related]
19. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
Pritchard J; Whelan R; Hill BT
Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
[No Abstract] [Full Text] [Related]
20. Dental abnormalities in children treated for neuroblastoma.
Kaste SC; Hopkins KP; Bowman LC; Santana VM
Med Pediatr Oncol; 1998 Jan; 30(1):22-7. PubMed ID: 9371385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
